Zentek Ltd. Announces Management Transition Amidst Strategic Shift

GUELPH, ON / ACCESS Newswire / July 11, 2025 — Zentek Ltd. (“Zentek” or the “Company”), a health care company operating in the metals & mining sector, has announced a significant management transition. The company, known for its development of nano-material technologies and composites, particularly graphene materials derived from its Albaony deposit, has decided not to extend the consulting contract of its Chief Executive Officer, Greg Fenton, when it expires on March 31, 2026.

The decision, confirmed by multiple sources including StockWatch, Investing.com, Seeking Alpha, and CEO.ca, marks a pivotal moment for Zentek as it shifts its strategic focus. The board of directors has initiated a search for Fenton’s successor, emphasizing the need for leadership that will steer the company from its current research and development phase towards commercialization.

During his tenure, Fenton served as CEO for seven years, overseeing the company’s growth and diversification. His leadership saw Zentek navigate the challenges of the metals & mining sector while expanding its technological capabilities. The board has expressed its commitment to finding a new CEO who will continue to build on this foundation and drive the company’s transition to a more commercially focused entity.

In the interim, Zentek’s current executive team will maintain leadership responsibilities, ensuring continuity and stability as the search for a new CEO progresses. This transition comes at a time when Zentek’s financial metrics reflect both challenges and potential. The company’s close price on July 9, 2025, was CAD 1.45, with a 52-week high of CAD 2.5 and a low of CAD 0.75. The market capitalization stands at CAD 153,920,000, and the price-to-earnings ratio is currently -13.85, indicating ongoing financial adjustments.

Additionally, Zentek has been involved in a collaboration with Teufelberger, focusing on the recycling of strapping bands, as reported by Plasticker.de. This partnership highlights Zentek’s commitment to sustainable practices and innovation within its industry.

As Zentek navigates this management transition, stakeholders and investors will be closely watching the company’s strategic direction and its ability to capitalize on its technological advancements in the health care and metals & mining sectors. The company’s future success will depend on its ability to effectively transition from research and development to commercialization, under the guidance of new leadership.